anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Fraud Exposure

Framework collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 6,793
Current window 5,161-5,190
Pages 227
Rows per page 30
Framework: Fraud Exposureclear collectionreset all
18 30 60

Framework

5,161-5,190 of 6,793

filter-aware
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
127
The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
146
Uses yellow highlighting to emphasize key claims of deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
148
Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
154
Uses direct quotes from KOLs to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
158
Uses a series of quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
165
Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
204
The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
207
The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
208
Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
209
The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
210
Uses yellow highlighting to emphasize key incriminating phrases in the quotes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
211
The slide uses a combination of a trend line chart, a summary table of payment types, and a detailed table of specific recipient payments to build a case of financial impropriety.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
213
Uses a screenshot of an official government document to frame the company's business model as fraudulent.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
214
Uses yellow highlighting to emphasize key incriminating phrases in quotes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
216
The slide uses a series of quotes to build a narrative of corruption and unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
217
The slide uses highlighted text to emphasize key allegations of illegal payments and the prioritization of financial incentives over clinical evidence.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
222
Uses testimonial evidence to frame the company's sales practices as unethical and exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
224
Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
227
Uses testimonials from former executives and KOLs to support the thesis of financial abuse.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
232
The slide uses testimonials to frame the company's business model as predatory.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
233
Uses direct quotes from high-volume implanters to substantiate claims of systemic abuse in specific US regions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit